Delivery Order SPE2DB20D3103-SPE2DB25FP4W9
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,141.94 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp has been awarded a $92,175.01 delivery order by the Defense Logistics Agency (DLA) for Dupixent 300 mg/2 mL pens, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $22,154.31 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Dupixent 300 mg/2 ml pens. This firm fixed price, competitively awarded contract is a non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $51,903.30 on June 16, 2025, for the supply of Dupixent 300 mg/2 ml pens (2 ml) under a firm fixed price contract with no set-aside designation. The contract is scheduled for completion by June 17, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,617.14 by the Defense Logistics Agency on September 11, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $42,394.60 for the supply of Dupixent 300 mg/2 ml pens (2 ml units) under a Firm Fixed Price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitively awarded, non-set-aside contract. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 22, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $18,961.13. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 25, 2025, and performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $5,987.47 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitive award, issued under firm fixed pricing, represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $34,670.48 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract leveraging AmerisourceBergen's established pharmaceutical distribution capabilities. The contract is executed under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,934.34 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4W9Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,518.88 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Dupixent 300 mg/2 mL pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 15, 2025, and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor to federal medical procurement needs, including military and veteran healthcare systems. The company maintains a substantial prime IDC with the DLA valued at $999,999,999.00 through December 2026, which serves as the vehicle enabling fulfillment of diverse pharmaceutical supply requirements across multiple therapeutic domains and global military healthcare programs. This delivery order for Dupixent, a specialty pharmaceutical product, exemplifies the company's role in supplying both brand-name medications and specialized medical commodities to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 7/14/25 |